Can Psilocybin Help People With Prolonged Grief?
7/29/2025
University of Virginia School of Medicine researchers will examine whether psilocybin can help people who are experiencing persistent, intense grief, also known as prolonged grief disorder. Backed by a $895,866…
Research in Motion: Jung-Bum Shin, PhD
7/29/2025
We are working on hearing and deafness. We are especially interested in a cell type called the sensory hair cells that converts mechanical energy arising from sound vibrations into electrical…
Celebrating Our First Hoos Research Champions
7/29/2025
As one of the country’s top academic medical centers, research is central to our mission at the School of Medicine and UVA Health. Yet, the passionate, hardworking teams who drive…
7/22/2025
On the first Thursday of each month, the School of Medicine hosts a seminar highlighting two recently hired assistant professors. Each presenter gives a 30-minute introduction to their research program.…
Date: Aug 7, 2025 - Aug 7, 2025
Start Time: 4:00 pm
End Time: 5:00 pm
Scientists ID Rogue Antibodies in Patients After COVID
7/22/2025
Errant antibodies that regulate chemical reactions the way enzymes do could explain low blood pressure and other persistent symptoms that plague patients after COVID, new research from the University of…
Research in Motion: Swapnil Sonkusare, PhD
7/22/2025
My team at UVA focuses on proteins called ion channels. And we study how these ion channels in the vascular wall work together to maintain vascular health —Swapnil Sonkusare, PhD,…
GLP-1 Drugs Fail to Provide Key Weight-Loss Benefit
7/22/2025
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health,…
‘Mismatched’ Transplants Now Safe and Effective for Patients with Blood Cancer, Study Finds
7/15/2025
Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective “mismatched” transplants that will potentially cure their disease, new UVA…
